Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Jennifer Patnaik

Concepts (431)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Visual Acuity
32
2026
497
5.700
Why?
Macular Degeneration
17
2026
196
4.470
Why?
Cataract
18
2024
238
3.780
Why?
Geographic Atrophy
12
2025
103
3.460
Why?
Wet Macular Degeneration
8
2026
63
2.980
Why?
Phacoemulsification
14
2025
123
2.520
Why?
Registries
10
2025
2382
2.050
Why?
Diabetic Retinopathy
13
2024
211
2.030
Why?
Lenses, Intraocular
6
2022
49
1.810
Why?
Tomography, Optical Coherence
11
2025
277
1.740
Why?
Fluorescein Angiography
10
2026
195
1.680
Why?
Ophthalmology
7
2026
121
1.620
Why?
Intraocular Pressure
12
2026
332
1.580
Why?
Cataract Extraction
11
2026
120
1.570
Why?
Follow-Up Studies
27
2026
5397
1.180
Why?
Optometrists
3
2026
11
1.160
Why?
Glaucoma
8
2025
253
1.130
Why?
Optometry
2
2025
8
1.100
Why?
Retinopathy of Prematurity
4
2026
183
1.090
Why?
Keratomileusis, Laser In Situ
3
2024
20
1.070
Why?
Aged, 80 and over
30
2026
8351
0.980
Why?
Retinal Detachment
6
2023
74
0.950
Why?
Photorefractive Keratectomy
2
2024
21
0.930
Why?
Fovea Centralis
1
2025
24
0.920
Why?
Acanthamoeba Keratitis
1
2025
4
0.910
Why?
Retrospective Studies
57
2026
17291
0.910
Why?
Eye Infections, Parasitic
1
2025
6
0.910
Why?
Myopia
7
2024
59
0.900
Why?
Keratotomy, Radial
2
2022
10
0.890
Why?
Aged
52
2026
26251
0.860
Why?
Humans
126
2026
145625
0.810
Why?
Surveys and Questionnaires
16
2026
6050
0.800
Why?
Burnout, Professional
3
2025
489
0.780
Why?
Refraction, Ocular
6
2024
47
0.760
Why?
Female
79
2026
79080
0.720
Why?
Capsule Opacification
2
2021
22
0.720
Why?
Intraoperative Complications
6
2024
154
0.710
Why?
Presbyopia
1
2022
14
0.690
Why?
Retinal Drusen
4
2024
31
0.690
Why?
Eye Diseases
2
2020
98
0.690
Why?
Posterior Capsulotomy
1
2021
8
0.680
Why?
Uveitis
4
2025
151
0.680
Why?
Posterior Capsule of the Lens
1
2021
11
0.680
Why?
Trabeculectomy
5
2025
75
0.670
Why?
Lasers, Solid-State
1
2021
22
0.670
Why?
Male
72
2026
73014
0.670
Why?
National Eye Institute (U.S.)
1
2020
6
0.660
Why?
Automobile Driving
2
2022
156
0.630
Why?
Colorado
22
2026
4588
0.620
Why?
Middle Aged
41
2026
36359
0.620
Why?
Glaucoma, Open-Angle
4
2023
105
0.610
Why?
Retinal Neovascularization
1
2019
29
0.600
Why?
Laser Therapy
1
2021
146
0.590
Why?
Dementia
1
2023
322
0.580
Why?
Vitrectomy
6
2025
74
0.570
Why?
Estrogen Replacement Therapy
1
2019
144
0.560
Why?
Postoperative Complications
7
2026
2962
0.560
Why?
Lens, Crystalline
1
2020
136
0.550
Why?
Lasers, Excimer
3
2024
30
0.530
Why?
Metformin
1
2021
328
0.520
Why?
Angiogenesis Inhibitors
3
2026
238
0.520
Why?
Strabismus
3
2023
71
0.510
Why?
Complement Activation
5
2025
412
0.500
Why?
West Nile Fever
3
2011
57
0.500
Why?
Internal Medicine
1
2019
279
0.480
Why?
Laser Coagulation
3
2026
80
0.480
Why?
Cross-Sectional Studies
13
2026
5875
0.470
Why?
Emergency Medicine
1
2019
278
0.470
Why?
Refractive Errors
3
2025
36
0.470
Why?
Choroid
3
2025
80
0.460
Why?
Complement System Proteins
4
2025
324
0.460
Why?
Prevalence
7
2025
2852
0.450
Why?
Family Practice
1
2019
422
0.450
Why?
Self Report
2
2022
869
0.440
Why?
Vascular Endothelial Growth Factor A
4
2026
543
0.410
Why?
Breast Neoplasms
3
2011
2411
0.410
Why?
United States
19
2026
16041
0.410
Why?
Lens Implantation, Intraocular
5
2022
80
0.400
Why?
Cornea
3
2025
156
0.400
Why?
Sickness Impact Profile
2
2026
67
0.400
Why?
Biomarkers
9
2025
4329
0.400
Why?
Internet
4
2023
656
0.400
Why?
Corneal Transplantation
2
2025
17
0.390
Why?
Multimodal Imaging
2
2025
138
0.390
Why?
Glucocorticoids
4
2026
536
0.390
Why?
Commerce
2
2013
80
0.380
Why?
Vitreous Body
4
2022
118
0.380
Why?
Diabetes Mellitus
5
2024
1101
0.380
Why?
Fluocinolone Acetonide
2
2023
14
0.370
Why?
Smoking Prevention
1
2013
168
0.360
Why?
Tobacco Products
1
2013
90
0.350
Why?
Risk Factors
14
2025
10840
0.350
Why?
Ophthalmologic Surgical Procedures
2
2025
91
0.350
Why?
Macula Lutea
2
2023
21
0.350
Why?
Disease Progression
5
2026
2857
0.340
Why?
Fundus Oculi
3
2025
89
0.330
Why?
Disease Notification
2
2011
16
0.330
Why?
Retinal Diseases
2
2023
101
0.330
Why?
Lens Capsule, Crystalline
2
2021
13
0.330
Why?
Telemedicine
3
2026
956
0.320
Why?
Complement Factor B
2
2022
106
0.310
Why?
Quality of Life
6
2026
3187
0.310
Why?
Ophthalmologists
2
2026
21
0.300
Why?
Comorbidity
2
2011
1652
0.290
Why?
Eye Injuries
2
2021
53
0.290
Why?
Treatment Outcome
12
2026
11744
0.290
Why?
Tonometry, Ocular
3
2025
104
0.290
Why?
Artificial Intelligence
2
2024
385
0.290
Why?
Proportional Hazards Models
3
2026
1318
0.290
Why?
Diabetes Mellitus, Type 2
4
2023
2623
0.280
Why?
Tertiary Care Centers
2
2026
194
0.270
Why?
Infant
13
2026
10093
0.260
Why?
Hepatitis A
2
2011
25
0.260
Why?
Bangladesh
3
2022
64
0.260
Why?
West Nile virus
1
2007
41
0.260
Why?
Healthcare Disparities
2
2025
728
0.250
Why?
Gestational Age
4
2026
989
0.250
Why?
Time Factors
7
2025
7079
0.250
Why?
Adult
24
2026
40821
0.250
Why?
Local Government
1
2006
27
0.240
Why?
Health Promotion
1
2013
786
0.240
Why?
Pars Planitis
1
2026
6
0.240
Why?
Restaurants
1
2006
25
0.240
Why?
Prospective Studies
7
2025
8087
0.230
Why?
Chronic Disease
2
2011
1824
0.230
Why?
Blepharitis
1
2026
8
0.230
Why?
Vision Disorders
3
2022
178
0.230
Why?
Keratoconjunctivitis
1
2026
11
0.230
Why?
Mass Screening
2
2024
1300
0.230
Why?
Public Health Administration
1
2006
69
0.230
Why?
Scleritis
2
2025
28
0.230
Why?
Retinal Degeneration
1
2026
40
0.230
Why?
Blindness
1
2026
51
0.230
Why?
Eye Proteins
1
2026
93
0.230
Why?
Visual Fields
1
2026
116
0.220
Why?
Chemokine CCL5
2
2023
40
0.220
Why?
Dry Eye Syndromes
1
2026
56
0.220
Why?
Ciliary Body
1
2025
40
0.220
Why?
Pilocarpine
1
2025
16
0.220
Why?
Keratoconus
1
2025
23
0.220
Why?
Pemphigoid, Benign Mucous Membrane
1
2024
6
0.210
Why?
Withholding Treatment
1
2025
77
0.210
Why?
Occupational Stress
1
2025
46
0.210
Why?
Surgery, Plastic
1
2025
53
0.210
Why?
Birth Weight
3
2022
521
0.210
Why?
Education, Distance
1
2025
59
0.210
Why?
Retinoblastoma
1
2024
53
0.210
Why?
Aberrometry
2
2021
9
0.210
Why?
Child
14
2026
22638
0.200
Why?
Optics and Photonics
2
2021
38
0.200
Why?
Young Adult
7
2026
14240
0.200
Why?
Adolescent
12
2026
22451
0.200
Why?
Macular Edema
1
2023
49
0.190
Why?
Postoperative Period
5
2025
344
0.190
Why?
Insulins
1
2023
39
0.190
Why?
Feasibility Studies
2
2024
1125
0.190
Why?
Eye Burns
1
2022
14
0.190
Why?
Job Satisfaction
1
2025
235
0.190
Why?
Vision, Low
1
2022
16
0.190
Why?
Clinical Decision-Making
1
2026
364
0.180
Why?
Endoscopy
1
2025
316
0.180
Why?
Homosexuality, Male
2
2020
231
0.180
Why?
Outpatient Clinics, Hospital
1
2023
80
0.180
Why?
Cohort Studies
6
2022
6045
0.180
Why?
Eyelid Diseases
1
2022
26
0.180
Why?
Compartment Syndromes
1
2022
36
0.180
Why?
Odds Ratio
4
2019
1070
0.180
Why?
Corneal Ulcer
1
2022
21
0.180
Why?
Retinal Perforations
1
2022
18
0.180
Why?
Eyeglasses
1
2022
26
0.180
Why?
Incidence
5
2022
2910
0.180
Why?
Clothing
1
2022
23
0.180
Why?
Infant, Newborn
6
2026
6449
0.170
Why?
Patient Satisfaction
2
2024
698
0.170
Why?
Ocular Hypertension
1
2022
71
0.170
Why?
Weapons
1
2021
8
0.170
Why?
Civil Disorders
1
2021
8
0.170
Why?
Political Activism
1
2021
9
0.160
Why?
Refractive Surgical Procedures
1
2021
7
0.160
Why?
Eye Banks
1
2020
7
0.160
Why?
Neonatal Screening
1
2022
185
0.160
Why?
Perception
2
2021
372
0.160
Why?
Glaucoma Drainage Implants
1
2021
47
0.160
Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
Why?
Child, Preschool
10
2026
11888
0.160
Why?
Glycation End Products, Advanced
1
2021
84
0.160
Why?
Accidents, Traffic
1
2022
192
0.160
Why?
SEER Program
2
2011
233
0.160
Why?
Health Services Accessibility
2
2026
1101
0.150
Why?
Scleral Buckling
1
2019
16
0.150
Why?
Neurodegenerative Diseases
1
2022
147
0.150
Why?
Retinal Hemorrhage
1
2019
21
0.150
Why?
Language
1
2023
313
0.150
Why?
Vitreoretinopathy, Proliferative
1
2019
15
0.150
Why?
Hepatitis C
1
2022
250
0.150
Why?
Legislation, Drug
1
2020
72
0.150
Why?
Health Status Disparities
1
2023
321
0.150
Why?
Protective Factors
1
2019
97
0.150
Why?
Head Injuries, Closed
1
2019
49
0.150
Why?
MAP Kinase Kinase 1
1
2019
70
0.150
Why?
Oculomotor Muscles
1
2020
86
0.150
Why?
Complement Membrane Attack Complex
1
2019
38
0.150
Why?
Specialization
1
2020
136
0.150
Why?
Complement C3a
1
2019
40
0.150
Why?
Risk Assessment
3
2019
3678
0.140
Why?
Uveitis, Posterior
1
2019
12
0.140
Why?
Accreditation
1
2019
100
0.140
Why?
Cardiovascular Diseases
1
2011
2218
0.140
Why?
Refugees
1
2020
83
0.140
Why?
Choroidal Neovascularization
1
2019
57
0.140
Why?
Medical Marijuana
1
2020
119
0.140
Why?
Down Syndrome
1
2025
529
0.140
Why?
Case-Control Studies
3
2022
3633
0.140
Why?
Patient Care
1
2019
120
0.140
Why?
Glaucoma, Angle-Closure
1
2018
23
0.130
Why?
Infant, Premature
1
2022
622
0.130
Why?
Curriculum
1
2025
1074
0.130
Why?
Attitude of Health Personnel
1
2026
1212
0.130
Why?
Health Services Needs and Demand
1
2020
283
0.130
Why?
Trabecular Meshwork
1
2018
74
0.130
Why?
Proto-Oncogene Proteins B-raf
1
2019
230
0.130
Why?
Sexually Transmitted Diseases
3
2004
163
0.130
Why?
Practice Patterns, Physicians'
1
2026
1370
0.120
Why?
Marijuana Smoking
1
2020
248
0.120
Why?
Marijuana Use
1
2020
218
0.120
Why?
Logistic Models
2
2019
2112
0.110
Why?
Clinical Competence
2
2025
1261
0.110
Why?
Population Surveillance
2
2011
477
0.110
Why?
Disease Management
1
2019
649
0.110
Why?
Recovery of Function
1
2019
721
0.110
Why?
Aging
1
2026
1983
0.110
Why?
Inflammation
3
2023
2915
0.110
Why?
Education, Medical, Graduate
1
2019
566
0.100
Why?
Disease Outbreaks
2
2008
420
0.100
Why?
Retinal Pigment Epithelium
2
2024
81
0.100
Why?
Condoms
2
2004
99
0.100
Why?
Intravitreal Injections
2
2026
73
0.100
Why?
Physicians
1
2022
954
0.100
Why?
Melanoma
1
2019
764
0.090
Why?
Sexual Behavior
4
2004
489
0.090
Why?
Research Design
1
2019
1139
0.090
Why?
Skin Neoplasms
1
2019
805
0.090
Why?
Medicare
2
2024
907
0.090
Why?
Axial Length, Eye
2
2024
16
0.090
Why?
Hypoglycemic Agents
1
2021
1411
0.090
Why?
Immunologic Factors
2
2024
244
0.080
Why?
Diagnostic Errors
1
2011
178
0.080
Why?
Shellfish Poisoning
1
2009
1
0.080
Why?
Vibrio Infections
1
2009
2
0.080
Why?
Shellfish
1
2009
6
0.080
Why?
Food Industry
1
2009
8
0.080
Why?
Primary Prevention
1
2011
222
0.070
Why?
Food Microbiology
1
2009
39
0.070
Why?
Sex Factors
2
2025
2101
0.070
Why?
Cause of Death
1
2011
455
0.070
Why?
Kaplan-Meier Estimate
1
2011
959
0.070
Why?
Mortality
1
2011
375
0.070
Why?
Internship and Residency
1
2019
1269
0.070
Why?
Cryptosporidiosis
1
2008
22
0.070
Why?
Antineoplastic Agents
1
2019
2218
0.070
Why?
Anti-Inflammatory Agents
2
2022
473
0.070
Why?
Academic Medical Centers
2
2022
560
0.070
Why?
Disease Reservoirs
1
2007
27
0.070
Why?
Maternal-Child Health Centers
1
2007
8
0.070
Why?
Culicidae
1
2007
33
0.070
Why?
Sentinel Surveillance
1
2007
48
0.070
Why?
Gastroenteritis
1
2008
63
0.060
Why?
Health Services Administration
1
2007
9
0.060
Why?
Chickens
1
2007
169
0.060
Why?
Relief Work
1
2007
18
0.060
Why?
Enzyme-Linked Immunosorbent Assay
2
2019
845
0.060
Why?
Telephone
1
2008
175
0.060
Why?
Geography
1
2007
186
0.060
Why?
Birds
1
2007
87
0.060
Why?
Health Care Surveys
1
2008
538
0.060
Why?
Horses
1
2007
229
0.060
Why?
Ethiopia
1
2026
43
0.060
Why?
Visual Field Tests
1
2026
32
0.060
Why?
Smoking
1
2013
1478
0.060
Why?
Diabetes Mellitus, Type 1
1
2023
3930
0.060
Why?
Environment
1
2007
295
0.060
Why?
Disasters
1
2007
101
0.060
Why?
Immunoglobulins
1
2006
162
0.060
Why?
Predictive Value of Tests
1
2011
2097
0.060
Why?
Immunization Programs
1
2007
194
0.060
Why?
Bevacizumab
1
2026
167
0.060
Why?
Databases, Factual
1
2011
1481
0.060
Why?
Corneal Topography
1
2025
25
0.060
Why?
Miotics
1
2025
6
0.060
Why?
Muscarinic Agonists
1
2025
14
0.060
Why?
Azathioprine
1
2025
43
0.050
Why?
Adalimumab
1
2025
53
0.050
Why?
Ganglionic Stimulants
1
2005
15
0.050
Why?
Tomography
1
2025
44
0.050
Why?
Lubricant Eye Drops
1
2024
9
0.050
Why?
Ontario
1
2024
91
0.050
Why?
Infliximab
1
2025
107
0.050
Why?
Benchmarking
1
2026
192
0.050
Why?
Mycophenolic Acid
1
2025
117
0.050
Why?
Conjunctivitis
1
2024
30
0.050
Why?
Rwanda
1
2024
35
0.050
Why?
Retinal Neoplasms
1
2024
47
0.050
Why?
Attitude to Health
1
2007
419
0.050
Why?
Ophthalmic Solutions
1
2024
82
0.050
Why?
Needs Assessment
1
2007
403
0.050
Why?
Capacity Building
1
2024
61
0.050
Why?
Patient Discharge
1
2011
991
0.050
Why?
Methotrexate
1
2025
234
0.050
Why?
Vision Tests
1
2023
22
0.050
Why?
Hospitals, County
1
2023
11
0.050
Why?
Pulmonary Disease, Chronic Obstructive
1
2011
926
0.050
Why?
Observational Studies as Topic
1
2023
133
0.050
Why?
Health Surveys
2
2021
511
0.050
Why?
Tobacco Use Disorder
1
2005
217
0.050
Why?
Postoperative Care
1
2025
292
0.050
Why?
Interleukin-4
1
2023
207
0.050
Why?
Complement Factor I
1
2022
12
0.050
Why?
Gonorrhea
1
2003
63
0.050
Why?
Mentors
1
2024
215
0.050
Why?
Electronic Health Records
1
2011
1208
0.040
Why?
Orbit
1
2022
67
0.040
Why?
Aqueous Humor
1
2022
41
0.040
Why?
Global Health
1
2025
402
0.040
Why?
Cluster Analysis
1
2023
494
0.040
Why?
Phenotype
2
2022
3186
0.040
Why?
Hospitals, Pediatric
1
2026
561
0.040
Why?
Nicotine
1
2005
334
0.040
Why?
Drug Implants
1
2022
83
0.040
Why?
Alanine Transaminase
1
2022
151
0.040
Why?
Reference Standards
1
2022
176
0.040
Why?
Capsulorhexis
1
2021
9
0.040
Why?
Communication Barriers
1
2023
129
0.040
Why?
Albumins
1
2022
119
0.040
Why?
Safety-net Providers
1
2023
132
0.040
Why?
Morbidity
1
2022
317
0.040
Why?
Dissent and Disputes
1
2021
18
0.040
Why?
Fibrinogen
1
2022
181
0.040
Why?
Retinal Ganglion Cells
1
2022
123
0.040
Why?
Hepacivirus
1
2022
236
0.040
Why?
Intraoperative Period
1
2020
68
0.040
Why?
Smoking Cessation
1
2005
440
0.040
Why?
Crowding
1
2021
37
0.040
Why?
Biometry
1
2021
66
0.040
Why?
Risk-Taking
1
2003
321
0.040
Why?
Immunosuppressive Agents
1
2025
824
0.040
Why?
Myotomy
1
2020
15
0.040
Why?
Myanmar
1
2020
7
0.040
Why?
Rupture
1
2020
90
0.040
Why?
Vision, Binocular
1
2020
47
0.040
Why?
Adrenal Cortex Hormones
1
2023
483
0.040
Why?
Eye Movements
1
2020
91
0.040
Why?
Health Education
1
2003
346
0.040
Why?
Survival Rate
1
2024
2078
0.040
Why?
HIV
1
2020
249
0.040
Why?
Chromatography, Liquid
1
2021
452
0.040
Why?
Canada
1
2020
430
0.040
Why?
Remission, Spontaneous
1
2019
39
0.040
Why?
C-Reactive Protein
1
2021
427
0.040
Why?
Attitude
1
2021
253
0.040
Why?
Microscopy, Acoustic
1
2018
10
0.040
Why?
Pilot Projects
1
2024
1878
0.040
Why?
Ophthalmoscopy
1
2018
38
0.040
Why?
Pyrimidinones
1
2019
124
0.040
Why?
Preoperative Period
1
2019
150
0.030
Why?
Exfoliation Syndrome
1
2018
10
0.030
Why?
Corneal Pachymetry
1
2018
16
0.030
Why?
Circadian Rhythm
1
2023
514
0.030
Why?
Pseudophakia
1
2018
21
0.030
Why?
Clinical Trials as Topic
1
2023
1062
0.030
Why?
Tandem Mass Spectrometry
1
2021
574
0.030
Why?
Ambulatory Care
1
2023
627
0.030
Why?
Severity of Illness Index
1
2026
2910
0.030
Why?
Disease-Free Survival
1
2019
777
0.030
Why?
Physical Examination
1
2019
236
0.030
Why?
Prosthesis Design
1
2020
357
0.030
Why?
Cost-Benefit Analysis
1
2020
632
0.030
Why?
Longitudinal Studies
1
2025
3005
0.030
Why?
Stents
1
2021
551
0.030
Why?
Ambulatory Care Facilities
3
2004
267
0.030
Why?
Delivery of Health Care
1
2024
942
0.030
Why?
Equipment Design
1
2018
519
0.030
Why?
Sex Characteristics
1
2022
798
0.030
Why?
Referral and Consultation
1
2022
878
0.030
Why?
Mental Health
1
2022
771
0.030
Why?
Sleep
1
2023
896
0.030
Why?
Reproducibility of Results
1
2023
3396
0.030
Why?
Multivariate Analysis
1
2019
1531
0.030
Why?
Program Evaluation
2
2011
945
0.030
Why?
Anxiety
1
2022
1118
0.030
Why?
Proteins
1
2020
1021
0.030
Why?
Child Abuse
1
2019
545
0.020
Why?
Anti-Bacterial Agents
1
2024
1935
0.020
Why?
Proteomics
1
2020
1202
0.020
Why?
T-Lymphocytes
1
2022
2007
0.020
Why?
Protein Kinase Inhibitors
1
2019
982
0.020
Why?
Depression
1
2022
1566
0.020
Why?
Pandemics
1
2021
1700
0.020
Why?
Animals
3
2009
38030
0.020
Why?
Legionellosis
1
2011
2
0.020
Why?
Blood Glucose
1
2021
2357
0.020
Why?
Prognosis
1
2019
4331
0.020
Why?
Medical Audit
1
2011
77
0.020
Why?
Whooping Cough
1
2011
59
0.020
Why?
Haemophilus Infections
1
2011
45
0.020
Why?
Hospitals, Urban
1
2011
140
0.020
Why?
International Classification of Diseases
1
2011
142
0.020
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2019
1996
0.020
Why?
Cryptosporidium
1
2008
15
0.020
Why?
Caliciviridae Infections
1
2008
18
0.020
Why?
Norovirus
1
2008
22
0.020
Why?
Aid to Families with Dependent Children
1
2007
3
0.020
Why?
Residence Characteristics
1
2011
385
0.020
Why?
Faculty
1
2008
151
0.020
Why?
Diphtheria-Tetanus-acellular Pertussis Vaccines
1
2007
94
0.020
Why?
Medically Uninsured
1
2007
134
0.020
Why?
Family Characteristics
1
2008
202
0.020
Why?
Sensitivity and Specificity
1
2011
1992
0.010
Why?
Pharmaceutical Preparations
1
2007
172
0.010
Why?
Guideline Adherence
1
2009
585
0.010
Why?
Maryland
1
2005
67
0.010
Why?
Administration, Topical
1
2005
153
0.010
Why?
Urban Health Services
1
2004
68
0.010
Why?
Acute Disease
1
2007
1033
0.010
Why?
Office Visits
1
2003
93
0.010
Why?
Syphilis
1
2003
39
0.010
Why?
Administration, Oral
1
2005
867
0.010
Why?
Antiretroviral Therapy, Highly Active
1
2003
278
0.010
Why?
Risk
1
2004
917
0.010
Why?
Mothers
1
2007
771
0.010
Why?
Urban Population
1
2004
496
0.010
Why?
HIV Infections
1
2003
3210
0.000
Why?
Patnaik's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)